FLT3 and acute myeloid leukemia: A potential diagnostic power of AML EVs was recently demonstrated by Kunz et al. Specifically, authors detected, in plasma EV RNA isolated from 16 pediatric AML patients at diagnosis, two leukemia-specific mutations, FLT3-ITD and NPM1, reflecting mutational status of matched leukemic blasts.